MAYBE you’ve promised yourself you’ll hit the gym five days a week and you’ve already skipped several sessions. Or perhaps ...
The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
The pathology of Alzheimer’s disease was identified in 1906. We remain with neither cure nor treatments that reverse symptoms or stop disease progression. Recently approved treatments have ...
I have a special interest in Alzheimer’s disease. For nearly 25 years, I practiced general neurology in Portland, Oregon, and ...
Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...
Gum disease appears to disrupt brain activity, potentially increasing a person's risk of cognitive decline. People with gum ...
The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought ...
INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...